Reports and informative resources provided by the TRO.
To acknowledge 10 years of operation in 2021, weÌýput together a review of our achievements to celebrate all things TRO - from funding successes, drug discoveries and project progressions from preclinical to clinical, to spin out contributions and the development of long-term industry relationships.Ìý We also highlight how our vision and values in the areas of Research, Innovation and Education contribute to wider ¹û¶³Ó°Ôº goals and how we will continue to build on an increasingly vibrant translational culture over the next 10 years. Ìý | |
Jane Kinghorn, Director at ¹û¶³Ó°Ôº Translational Research Office and Nick McNally, Managing Director Research ¹û¶³Ó°Ôº/¹û¶³Ó°ÔºH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.Ìý | |
Jane Kinghorn, ¹û¶³Ó°Ôº TRO DirectorÌýand Anne Lane, CEO at ¹û¶³Ó°Ôº Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at ¹û¶³Ó°Ôº and their partner hospitals. | |
Translational education and training for early career researchersIn this interview, Colby Benari, Head of the Academic Careers Office (ACO) at ¹û¶³Ó°Ôº, discusses the role and impact of the ¹û¶³Ó°Ôº ACO and highlights new translational training opportunities for Early Career Researchers.Ìý | |
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office)Ìýat ¹û¶³Ó°Ôº, explain the value of drug discovery in academia in bridging the "Valley of Death". | |
The innovation gameProfessor David Lomas discusses the Therapeutic Innovation Networks (TINs), which are facilitating and accelerating enterprise at ¹û¶³Ó°Ôº (¹û¶³Ó°Ôº), | |
Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from ¹û¶³Ó°Ôº, argue that the ability to listen and learn makes ¹û¶³Ó°Ôº a global partner of choice for health research and innovation.Ìý | |
Translating novel science to patient benefitDr Jane Kinghorn discusses how ¹û¶³Ó°Ôº (¹û¶³Ó°Ôº)’s Translational Research Office (TRO) is working to encourage, facilitate and contribute to the translation of ¹û¶³Ó°Ôºâ€™s and its partner hospitals’ research. | |
Cell, Gene and Regenerative Therapies at ¹û¶³Ó°Ôº and NHS Partner Trusts¹û¶³Ó°Ôº in partnership with our three NIHR BRCs at ¹û¶³Ó°Ôº Hospital (¹û¶³Ó°ÔºH), Great Ormond Street Hospital for Children (GOSH) and Moorfields Eye Hospital (MEH) are world leaders in the development and delivery to patients of novel cell, gene and regenerative therapies.Ìý | |
¹û¶³Ó°Ôº supporting Healthcare Leadership and Innovation capacity building in AfricaIn late 2018, ¹û¶³Ó°Ôºâ€™s Academic Careers Office (ACO) and Translational Research Office (TRO) along with ¹û¶³Ó°Ôº partner the Africa Health Research Institute (AHRI), were successful in applying for a UKRI Global Challenge Research Fund Impact Acceleration Award (GCRF IAA).ÌýThe ACO and TRO organised two events in South Africa open to participants from across the African continent. |